Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 10,165-10,176 of 10,661

Drug study icon

TerminatedNCT00725270

Treatment of Schizoaffective Disorder Using Mifepristone

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Stanford University
Condition: Depression, Schizophrenia

Drug study icon

CompletedNCT00498550

Treatment of Schizophrenia and Comorbid Addiction: Comparing Clozapine to Treatment-as-Usual

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia, Addiction

Behavioral study icon

CompletedNCT00051233

Treatment of Schizophrenia Through Internet-Based Psychoeducation

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

SchizophreniaBehavioralFrom 14 Years to 55 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Schizophrenia

Drug study icon

CompletedNCT02118610

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

CompletedNCT00796302

Treatment of Severe Childhood Aggression (The TOSCA Study)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Michael Aman
Condition: ADHD

Drug study icon

CompletedNCT00937235

Treatment of Smoking Among Individuals With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: PTSD, Addiction

Behavioral study icon

CompletedNCT01807871

Treatment of Smoking Lapses and Relapses

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: University of Vermont
Condition: Addiction

Other study type icon

CompletedNCT02246426

Treatment of Social Cognition in Schizophrenia study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Posit Science Corporation
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00183651

Treatment of Suicidal Women With Borderline Personality Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Washington
Condition: Suicidality

Drug study icon

CompletedNCT01887990

Treatment of Suicide prevention With Intravenous Ketamine Infusion

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Suicidality, DepressionDrugOver 19 Years

Countries: United States
Sponsor: University of Alabama at Birmingham
Condition: Suicidality, Depression

Drug study icon

TerminatedNCT01000064

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 16 Years to 45 Years

Countries: United States
Sponsor: Vanderbilt University
Condition: ADHD

Drug study icon

CompletedNCT02712996

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 16 Years

Countries: United States
Sponsor: Vanderbilt University
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.